These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14638491)

  • 1. Novel antibacterial class.
    Dandliker PJ; Pratt SD; Nilius AM; Black-Schaefer C; Ruan X; Towne DL; Clark RF; Englund EE; Wagner R; Weitzberg M; Chovan LE; Hickman RK; Daly MM; Kakavas S; Zhong P; Cao Z; David CA; Xuei X; Lerner CG; Soni NB; Bui M; Shen LL; Cai Y; Merta PJ; Saiki AY; Beutel BA
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3831-9. PubMed ID: 14638491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity.
    Beyer D; Kroll HP; Endermann R; Schiffer G; Siegel S; Bauser M; Pohlmann J; Brands M; Ziegelbauer K; Haebich D; Eymann C; Brötz-Oesterhelt H
    Antimicrob Agents Chemother; 2004 Feb; 48(2):525-32. PubMed ID: 14742205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
    J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.
    Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE
    Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
    Ishii Y; Ohno A; Yamaguchi K
    Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012].
    Zhao C; Zhang F; Wang Z; Cao B; Xu X; Sun H; Zhang R; Hu Y; Liu Z; Du Y; Chen R; Zhuo C; Su D; Liu Y; Hu B; Wang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):18-22. PubMed ID: 25791651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.
    Uria-Nickelsen M; Blodgett A; Kamp H; Eakin A; Sherer B; Green O
    Int J Antimicrob Agents; 2013 Jan; 41(1):28-35. PubMed ID: 23142086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 10. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and analysis of 4H-pyridopyrimidines, a class of selective bacterial protein synthesis inhibitors.
    Ribble W; Hill WE; Ochsner UA; Jarvis TC; Guiles JW; Janjic N; Bullard JM
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4648-57. PubMed ID: 20696870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
    Okubo T; Iyobe S; Fujiki Y; Sagai H
    Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Lee HY; Andalibi A; Webster P; Moon SK; Teufert K; Kang SH; Li JD; Nagura M; Ganz T; Lim DJ
    BMC Infect Dis; 2004 May; 4():12. PubMed ID: 15125783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
    Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.